Abstract: Systems, methods, and apparatuses for confidence mapping of shear wave measurements are disclosed. Confidence maps of shear wave image measurements may be generated from one or more confidence factors. Masking of graphical overlays of tissue stiffness values, based at least in part on the confidence map is disclosed. The confidence map and/or masked graphical overlays of tissue stiffness values may be superimposed on ultrasound images and provided on a display.

Abstract: A purification method of a recovered aluminum melt for an automobile hub includes nitrogen degassing of a gas permeable brick pouring ladle bottom layer arranged on a lower portion of a gas permeable brick pouring ladle and argon degassing of a rotor degasser arranged on an upper portion. The invention has a good degassing and deslagging effect and high purification efficiency, and achieves energy conservation and environmental protection.

Abstract: A platform for processing a workpiece includes a transmission mechanism, a plurality of workstations and a plurality of movable vehicles. The transmission mechanism transports the workpiece to be processed to one of the plurality of workstations. Each movable vehicle includes a processing module and a docking interface adapted to connect with a docking station of each workstation. The movable vehicles are each adapted to move in and out of each workstation, and each processing module is adapted to process the workpiece transmitted to the workstation after the movable vehicle is moved in and positioned in the workstation.

Abstract: Aspects of a storage device including a memory and a controller are provided. In certain aspects, the controller may determine that data stored on a first block satisfies a threshold data-error condition, the data comprising invalid data and valid data. For example, the first block may have a high ratio of valid data to invalid data that satisfies or exceeds a threshold value. In certain aspects, the controller may determine a close block boundary associated with the first block, wherein the close block boundary is configured to bifurcate the first block into a first portion and a second portion, wherein the first portion comprises the data. For example, the controller may determine a boundary defined by a data length, an indirection mapping unit, a physical program boundary, etc.

Abstract: A paper ejection apparatus including: paper ejection trays to which printed sheets are selectively ejected; a main tray disposed lower than the paper ejection trays; an inspection result acquirer configured to acquire an inspection result of each of the printed sheets; a paper ejection controller configured to control paper ejection such that each of the printed sheets is ejected to the paper ejection trays before the inspection result is obtained by the inspection result acquirer; and a tray information manager configured to manage by associating identification information of each of the paper ejection trays with the inspection result of each of the printed sheets ejected on the paper ejection trays.

Abstract: A paper ejection apparatus including: paper ejection trays to which printed sheets are selectively ejected; a main tray disposed lower than the paper ejection trays; an inspection result acquirer configured to acquire an inspection result of each of the printed sheets; a paper ejection controller configured to control paper ejection such that each of the printed sheets is ejected to the paper ejection trays before the inspection result is obtained by the inspection result acquirer; and a tray information manager configured to manage by associating identification information of each of the paper ejection trays with the inspection result of each of the printed sheets ejected on the paper ejection trays.

Abstract: This application discloses a novel process to synthesize 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds, which may be used, for example, as NK-1 inhibitor compounds in pharmaceutical preparations, intermediates useful in said process, and processes for preparing said intermediates; also disclosed is a process for removal of metals from N-heterocyclic carbine metal complexes.

Abstract: This application discloses a novel process to synthesize 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds, which may be used, for example, as NK-1 inhibitor compounds in pharmaceutical preparations, intermediates useful in said process, and processes for preparing said intermediates; also disclosed is a process for removal of metals from N-heterocyclic carbine metal complexes.

Abstract: This application discloses a novel process to synthesize 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds, which may be used, for example, as NK-1 inhibitor compounds in pharmaceutical preparations, intermediates useful in said process, and processes for preparing said intermediates; also disclosed is a process for removal of metals from N-heterocyclic carbine metal complexes.

Abstract: The present invention relates to synthetic processes useful in the preparation of compounds of Formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease and have application in the treatment of conditions caused by HCV. In particular, the present invention relates to novel oxidation processes useful for preparing compounds of Formula (I) and related compounds, including pharmaceutically acceptable salts, hydrates and solvates thereof, and including stereoisomers thereof.

Abstract: This application discloses a novel process to synthesize 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds, which may be used, for example, as NK-1 inhibitor compounds in pharmaceutical preparations, intermediates useful in said process, and processes for preparing said intermediates; also disclosed is a process for removal of metals from N-heterocyclic carbine metal complexes.

Abstract: This application discloses a novel process for the preparation of himbacine analogs useful as thrombin receptor antagonists. The process is based in part on the use of a base-promoted dynamic epimerization of a chiral nitro center.

Abstract: This application discloses a novel process for the preparation of himbacine analogs useful as thrombin receptor antagonists. The process is based in part on the use of a base-promoted dynamic epimerization of a chiral nitro center.